Clinical Trials Directory

Trials / Unknown

UnknownNCT04939974

Probiotic in Autism

Evaluation of the Efficacy of Oral Probiotics Supplementation in Children With Autism Spectrum Disorders (ASDs): a Randomized Double Blind, Placebo Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
All India Institute of Medical Sciences · Academic / Other
Sex
All
Age
2 Years – 18 Years
Healthy volunteers
Not accepted

Summary

One suitable probiotic packet will be administered to one group and placebo to another group of autism children and improvement in CARS will be monitored

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprobioticThe probiotic preparation selected for this study will contain use three species of probiotic bacterias namely Lactobacillus rhamnosus - ATCC 21052, Lactobacillus plantarum - ATCC 8014 and Bifidobacterium longum subsp. Infantis-ATCC 15707 at the dose of one billion (10 9 ) CFU/g of product (Total 3x10 9 CFU/g).

Timeline

Start date
2021-08-01
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2021-06-25
Last updated
2021-06-25

Source: ClinicalTrials.gov record NCT04939974. Inclusion in this directory is not an endorsement.